A First in Human Study of the Safety, Tolerability, and the Physiologically Based Pharmacokinetics of XFB19 in Healthy Adult Volunteers.

Clinical trial NCT05361733 · RECRUITING

Trial details

NCT number: NCT05361733
Sponsor: Xfibra, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Focus of the Study: Safety of XFB19

Start date: 2026-02-17
Primary completion: 2026-09-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.